Bull
$34.06
Scenario price
$42.510
+1.139 (+2.68%)At close
Appian Corporation provides process automation technology. Its platform has been leveraged by enterprises and governments. Its combining edge process orchestration and intelligence, provides everything an organization needs to design, automate, and optimize critical processes. Its capabilities include automation platform, unified data fabric, enterprise-grade controls, interactive design, and implementation. Its automation platform capabilities include business rules engines, pre-built connections, application program interface integrations, intelligent document processing (IDP), robotic process automation (RPA), and artificial intelligence (AI). Its patented data fabric is an integrated layer that unifies data across the enterprise without requiring companies to migrate their data, eliminating the need for additional systems, tools and time to insight. Its enterprise-grade controls deliver security, auditability, and enterprise guardrails to support workloads and confidential data.
Appian Corp (APPN) is a good buy right now, trading at $42.51 with a strong RSI of 81.67 indicating overbought conditions, but also reflecting strong momentum. The company reported Q2 revenue of $203.3 million, exceeding expectations by 19.1%, and raised its full-year revenue guidance to $849 million, showing confidence in continued growth. The main risk is the high forward P/E of 416.67, indicating that the stock may be overvalued based on earnings expectations.
DA Davidson
$34
2026-08-07
DA Davidson
2026-08-07
Price Target
$34
Citi
$40
2026-08-07
Citi
2026-08-07
Price Target
$40
Morgan Stanley
$32
2026-08-07
Morgan Stanley
2026-08-07
Price Target
$32
DA Davidson
$22
2026-05-15
DA Davidson
2026-05-15
Price Target
$22
TD Cowen
$24
2026-05-15
TD Cowen
2026-05-15
Price Target
$24
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Appian Reports Strong Q2 Earnings Driven by AI Adoption

Appian and Synechron Launch Open Underwriting Stack for Insurance Modernization

Appian Reports Strong Q2 Earnings, AI Strategy Shows Promise

Appian Beats Q2 Estimates and Raises Full-Year Guidance Amid Software Sector Sell-Off

Appian Reports Strong Q2 2026 Earnings with AI-Driven Growth
Appian Corporation provides process automation technology. Its platform has been leveraged by enterprises and governments. Its combining edge process orchestration and intelligence, provides everything an organization needs to design, automate, and optimize critical processes. Its capabilities include automation platform, unified data fabric, enterprise-grade controls, interactive design, and implementation. Its automation platform capabilities include business rules engines, pre-built connections, application program interface integrations, intelligent document processing (IDP), robotic process automation (RPA), and artificial intelligence (AI). Its patented data fabric is an integrated layer that unifies data across the enterprise without requiring companies to migrate their data, eliminating the need for additional systems, tools and time to insight. Its enterprise-grade controls deliver security, auditability, and enterprise guardrails to support workloads and confidential data. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
Appian Corp (APPN) is a good buy right now, trading at $42.51 with a strong RSI of 81.67 indicating overbought conditions, but also reflecting strong momentum. The company reported Q2 revenue of $203.3 million, exceeding expectations by 19.1%, and raised its full-year revenue guidance to $849 million, showing confidence in continued growth. The main risk is the high forward P/E of 416.67, indicating that the stock may be overvalued based on earnings expectations.
6 analysts cover APPN: 0 rate it Buy, 6 Hold and 0 Sell. The average price target is 42.33.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.